Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept
Abstract Background To study the clinical outcomes of pigment epithelial detachment (PED) associated with neovascular age-related macular degeneration (nAMD) in patients switched from Ranibizumab to Aflibercept. Methods Retrospective non-comparative case series. 50 eyes with active nAMD and fovea in...
Main Authors: | Pallavi Tyagi, Zain Juma, Yong Keen Hor, Neil W. Scott, Andreea Ionean, Cynthia Santiago |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12886-018-0824-0 |
Similar Items
-
12-month outcomes of ziv-aflibercept for neovascular age-related macular degeneration in eyes previously treated with aflibercept
by: Wajiha J Kheir, et al.
Published: (2025-01-01) -
Aflibercept Treatment Results and Association with Baseline Characteristics in Cases of Newly Diagnosed Neovascular Age-Related Macular Degeneration
by: Pelin Kıyat, et al.
Published: (2021-06-01) -
Comparison of the regressive effects of aflibercept and brolucizumab on pigment epithelial detachment
by: Ryo Mukai, et al.
Published: (2022-09-01) -
Exploring the comparative regressive effects of aflibercept and faricimab on pigment epithelial detachment
by: Ryo Mukai, et al.
Published: (2024-09-01) -
Patient adherence to therapy after switch to aflibercept from bevacizumab or ranibizumab for treatment-refractory neovascular age-related macular degeneration
by: Simon D Archambault, et al.
Published: (2024-01-01)